Zepbound works by activating two gut hormone receptors at once, mimicking natural signals that control appetite, digestion, and blood sugar. This dual action is what sets it apart from older weight loss medications that target only one of these pathways. The drug is a synthetic peptide you inject once a week, and in clinical trials, people on the highest dose lost an average of 20.9% of their body weight over 72 weeks.
Two Hormones, One Drug
Your gut naturally produces two hormones after you eat: GLP-1 and GIP. Both signal your pancreas to release insulin and tell your brain you’ve had enough food, but they do so through slightly different pathways and in different parts of the body. Most weight loss injections on the market (like Wegovy) mimic only GLP-1. Zepbound mimics both.
The drug binds to GIP receptors with roughly the same strength as your body’s own GIP. Its grip on GLP-1 receptors is about five times weaker than natural GLP-1, but that’s by design. Research shows that activating both receptors together produces a stronger insulin response and a greater suppression of the hunger hormone glucagon than activating either one alone. The combination is sometimes called “twincretin” therapy.
How It Reduces Appetite
Zepbound reaches areas of the brain that regulate hunger and feeding behavior. In animal studies, fluorescently labeled versions of the drug showed up in brain regions near the brainstem and hypothalamus, areas that act as control centers for appetite. GIP and GLP-1 receptors are both present in the brain, but they don’t fully overlap in location, which means the drug influences appetite through a broader network of signals than a GLP-1-only medication can.
One interesting finding: the GIP component appears to soften some of the unpleasant side effects triggered by GLP-1 receptor activation. GLP-1 drugs are known for causing nausea partly because they activate an area of the brainstem called the area postrema, which controls aversive responses like the urge to vomit. GIP receptor activation in that same region appears to dial down those signals. This doesn’t eliminate nausea entirely (about 44% of people in head-to-head trials still experienced it), but it may explain why the drug can push weight loss further without a proportional increase in side effects.
Slowed Digestion and Fullness
Beyond the brain, Zepbound slows the rate at which your stomach empties food into the small intestine. When food sits in the stomach longer, you feel full sooner during a meal and stay full afterward. This is a direct effect of GLP-1 receptor activation in the digestive tract. If you already have slow gastric emptying, this effect can become more pronounced and may worsen symptoms like bloating.
The slower stomach emptying also affects how quickly your body absorbs other oral medications. If you take pills that need to be absorbed on a predictable schedule, your prescriber may need to adjust the timing.
What GIP Does to Fat Tissue
The GIP side of the equation has effects that go beyond appetite. GIP receptors are found in fat tissue, bone, the heart, and the adrenal glands. In fat tissue specifically, GIP improves the body’s ability to store dietary fat properly in fat cells rather than letting it “spill over” into the liver, muscles, and bloodstream, where excess fat causes metabolic damage. This lipid buffering effect may help improve insulin sensitivity independently of the weight you lose, which is why some researchers believe the GIP component accounts for the added metabolic benefit tirzepatide shows over GLP-1-only drugs.
How Much Weight People Lose
In the SURMOUNT-1 trial, adults with obesity (but without type 2 diabetes) took Zepbound for 72 weeks alongside a reduced-calorie diet and exercise. Average weight loss broke down by dose: 15% of body weight at 5 mg, 19.5% at 10 mg, and 20.9% at 15 mg.
A head-to-head trial called SURMOUNT-5 put Zepbound directly against Wegovy at maximum doses in 751 people with obesity. Participants on Zepbound lost about 50 pounds (20.2% of body weight), while those on Wegovy lost about 33 pounds (13.7%). Nearly a third of people on Zepbound hit the 25% weight loss mark, compared with 16% on Wegovy. Side effect rates were similar between the two drugs: roughly 44% experienced nausea and 25% reported abdominal pain in both groups.
Dosing and How It Ramps Up
Zepbound starts at 2.5 mg once weekly, which is not a treatment dose. It exists purely to let your body adjust. After four weeks, the dose increases to 5 mg, which is the lowest maintenance dose for weight management. From there, your prescriber can increase by 2.5 mg increments every four weeks or longer, up to a maximum of 15 mg. The gradual ramp-up helps minimize gastrointestinal side effects as your body adapts to slower digestion and reduced appetite.
For weight reduction alone, 5 mg, 10 mg, or 15 mg are all approved maintenance doses. For the specific indication of moderate-to-severe obstructive sleep apnea with obesity, only 10 mg or 15 mg are recommended.
Who Qualifies for a Prescription
The FDA approved Zepbound for adults with a BMI of 30 or higher, or a BMI of 27 or higher if they also have at least one weight-related health condition. Qualifying conditions include high blood pressure, abnormal cholesterol, type 2 diabetes, obstructive sleep apnea, or cardiovascular disease. The approval specifies it should be used alongside a reduced-calorie diet and increased physical activity.
What Happens If You Stop
Weight regain after stopping is a real consideration. In the SURMOUNT-4 trial, people took Zepbound for 36 weeks and then were randomly assigned to either continue the drug or switch to a placebo for another 52 weeks. Those who stayed on Zepbound lost an additional 5.5% of their body weight. Those switched to placebo regained 14% over the same period. That’s a nearly 20 percentage point gap, which underscores that the drug’s effects on appetite and metabolism are ongoing, not permanent. The hunger signals and metabolic patterns it suppresses return when the medication stops.
This doesn’t mean everyone regains all the weight, but it does mean Zepbound works best as a long-term treatment rather than a short course. The biological mechanisms it targets, appetite regulation, gastric emptying, fat tissue signaling, are active only while the drug is in your system.